Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Infection route ‘key’ to swine flu vaccine testing
Piglets
Scientists analysed the amount of viral shedding and immune response from pigs after infection with a high and low dose of swine flu virus.

Study finds natural infection is the most efficient route

Swine flu vaccine testing must consider the route of infection, as this has a greater impact on results than previously thought, according to new research.

In experiments, scientists administer the influenza A virus (IAV) to pigs intra-nasally, intra-tracheally or by aerosol. Yet, few studies have compared the outcomes of the various methods.

Now, new research by The Pirbright Institute suggests that the route of infection and dosage does have a major effect on the outcome.

In the study, published in Veterinary Research, scientists analysed the amount of viral shedding and immune response from pigs after infection with a high and low dose of swine flu virus.  Using intral-nasal and aerosol routes of administration, they also compared the outcomes with pigs infected through contact transmission - or the ‘natural route’.

The results show that the way the virus multiplies in the animal, and the immune response in naturally infected animals, differs from those of animals experimentally infected with different doses and methods.

The scientists found that pigs can be infected with a much lower dose of the virus when administered by aerosol rather than intra-nasally.

While animals infected intra-nasally needed a larger dose to establish an infection, the pigs produced more virus and were better able to transmit it once infected. In contrast, those infected with a high dose did not transmit it effectively.

The study also found that virus administered by aerosol was more effective than intra-nasally at reaching the lower respiratory tract (LRT).

The team say this suggests that virus replication in the LRT is better contained than the virus in the upper respiratory tract (URT) and less likely to be emitted as a result. 'This indicates that replication in the URT is the source of virus for both direct contact and airborne transmission,' they write.

Furthermore, the team found that natural infection by contact was the most efficient route - inducing a strong immune response, even when they exposed the animals to a low dose.

“Our comparison of intranasal, aerosol and contact infected animals shows that the route of infection and the dose of infectious virus have major effects on the outcome in terms of infectivity, viral shedding, immune response and pathology and should, therefore, be taken into consideration in experiments testing new vaccines or drugs,” explained Dr Elma Tchilian, group leader for swine influenza immunology.

“Furthermore, while the ‘natural’ contact route of infection may be the most effective, this approach requires the use of more animals and therefore a low dose of a virus using aerosol, may be the next best alternative in such studies”.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.